BOT:ASX
Botanix Pharmaceuticals Ltd
A$ 0.010
0.00%
(0.00) Siku 1
9 Nov, 09:59:07 GMT +11 · AUD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya BOT...
Fungua
A$ 0.01
Juu
A$ 0.01
Chini
A$ 0.01
Mtaji wa soko
27.63M
Wastani wa kiasi cha mauzo
9.97M
Kiasi cha mauzo ya hisa
elfu 32.98
Juu kwa wiki 52
A$ 0.15
Chini kwa wiki 52
A$ 0.01
EPS
-A$ 0.03
Hisa za wawekezaji
2.76B
Idadi ya wafanyakazi
11
Fungua
A$ 0.01
Juu
A$ 0.01
Chini
A$ 0.01
Mtaji wa soko
27.63M
Wastani wa kiasi cha mauzo
9.97M
Kiasi cha mauzo ya hisa
elfu 32.98
Juu kwa wiki 52
A$ 0.15
Chini kwa wiki 52
A$ 0.01
EPS
-A$ 0.03
Hisa za wawekezaji
2.76B
Idadi ya wafanyakazi
11
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Investor's Business Daily
·
saa 1 iliyopita
Dow Jones Futures Loom For Damaged Market; Nvidia Probes Huang Spying Case
24/7 Wall St.
·
saa 1 iliyopita
Bitcoin's Correlation With the S&P 500 Just Hit 0.80. Is Bitcoin Trading Like a Tech Stock Again?
FXStreet
·
saa 1 iliyopita
Weekly column: Strong jobs report defies rate hikes as NASDAQ breaks primary cycle lows
Wasifu
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Kuhusu Botanix Pharmaceuticals Ltd
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi11
Lilianzishwa1984
Makao makuu-
SektaHealth Care
Sekta-
Tovutibotanixpharma.com